hxxps://braeburnrx[.]com/braeburns-brixadi-buprenorphine-extended-release-subcutaneous-injection-ciii-receives-fda-approval-for-moderate-to-severe-opioid-use-disorder/

General

Target

https://braeburnrx.com/braeburns-brixadi-buprenorphine-extended-release-subcutaneous-injection-ciii-receives-fda-approval-for-moderate-to-severe-opioid-use-disorder/
Sample

230714-jqnx2scf93

Score

1^/10

Initial Access

Execution

Persistence

Privilege Escalation

Defense Evasion

Credential Access

Discovery

Query Registry

System Information Discovery

Lateral Movement

Collection

Command and Control

Exfiltration

Impact